Treatment Sequencing in HR+ mBC
ASCO® 2023 Insights: "Primary Efficacy Analyses of NeoRHEA, Neoadjuvant Biomarker Research Study of Palbociclib Combined With ET in ER+/HER2- BC"
Login to view comments.
Click here to Login
Treatment Sequencing in HR+ mBC